Myeloma Today: Summer 2023
In the summer 2023 edition, IMF Chairman of the Board and Chief Scientific Officer Brian G.M. Durie, MD, discusses the 14th Annual Summit of the IMF’s International Myeloma Working Group (IMWG), as well as key data presented at the annual congresses of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). IMF Chief Medical Officer Joseph Mikhael, MD, discusses studies of CAR T-cell therapies that demonstrate promise earlier in the course of myeloma. Also, the IMF honors María-Victoria Mateos, MD, PhD, and Thomas Martin, MD, for their outstanding work in myeloma research; the IMF’s Nurse Leadership Board (NLB) launches Myeloma University, an educational resource to help nurses and other healthcare professionals keep up with the rapid changes in myeloma care; the IMF’s Global Myeloma Action Network (GMAN) convenes its 10th Annual GMAN Summit; and more.